Members
Minnesota
Jithma P. Abeykoon, M.D.
Dr. Jithma P. Abeykoon, M.D., is a hematologist‑oncologist and a member of the faculty at Mayo Clinic in Rochester, Minnesota. He currently holds the positions of assistant professor of medicine and oncology at the Mayo Clinic College of Medicine and Science, and senior associate consultant in the Division of Hematology, Department of Internal Medicine.
Dr. Abeykoon earned his medical degree from the University of Kansas, where he graduated at the top of his class. He went on to complete residency training in internal medicine at Mayo Clinic’s Graduate Medical Education program, followed by fellowship training in hematology/oncology.
In his clinical work, Dr. Abeykoon focuses on lymphomas, dysproteinemias, histiocytic disorders, and other rare hematologic malignancies. He maintains an active interest in translational and basic science research, particularly in molecular and genetic drivers of blood cancers, and has published extensively on topics including non‑Hodgkin lymphoma and nucleocytoplasmic trafficking in malignancy.
Dr. Abeykoon has received several honors, including the Mayo Brothers Distinguished Fellowship Award and merit awards from Conquer Cancer (ASCO). He is active in mentoring, medical education, and service in professional societies such as the American Society of Hematology and the American Society of Clinical Oncology.
Aneel A. Ashrani, M.D., M.S.
Dr. Aneel A. Ashrani, M.D., M.S., is a hematologist-oncologist at the Mayo Clinic in Rochester, Minnesota, with a distinguished career spanning clinical care, research, and education. He holds board certifications in internal medicine, medical oncology, and hematology, and maintains a focused practice in bleeding and thrombotic disorders.
Dr. Ashrani earned his medical degree from Grant Government Medical College in 1994. He completed internship and residency in internal medicine at the State University of New York at Stony Brook and later pursued fellowship training in hematology, oncology, and transplantation at the University of Minnesota, where he also earned his master’s degree in clinical research.
At Mayo Clinic, he serves as program director for both the Special Coagulation Laboratory Fellowship and the Advanced Clinical Coagulation Fellowship, shaping future leaders in coagulation medicine. Dr. Ashrani has authored over 100 peer-reviewed articles, book chapters, and abstracts, and has received multiple awards for excellence in teaching and research.
Clinically, his expertise spans disorders such as hemophilia, von Willebrand disease, thrombophilia, thrombophlebitis, and leukemias. Through a combination of patient care, laboratory medicine, and scholarly work, Dr. Ashrani continues to contribute significantly to the field of hemostasis and thrombosis.
Michelle A. Elliott, M.D.
Michelle Elliott, M.D.is a consultant and associate professor of medicine at Mayo Clinic. She completed her residency and fellowship training in internal medicine and hematology/oncology, respectively at Mayo Clinic. She is currently board certified in internal medicine, hematology, medical oncology and obesity medicine.
Dr. Elliott is co-chair of the Hematology-Oncology Pharmaceutical Formulary Task Force Committee. She has held various academic and clinical positions at Mayo Clinic, including director of the General Coagulation Laboratory, chair of the Pharmacogenomics Task Force Committee, and chair of the Rochester Acute Leukemia and Myeloid Neoplasm Disease Oriented Group. She has received several honors and awards, such as the Foundation Scholarship from Trnity College, the University of Dublin, the Practice Development Award from the Department of Internal Medicine, Mayo Clinic, and the Mayo Clinic Patient Experience Award.
Dr. Elliott has been involved in education, service, research and clinical practice in the fields of benign and malignant hematology. She has published over 100 peer-reviewed articles, book chapters and abstracts on various topics related to benign and hematology. She has a particular clinical and research interest in diosrders of the neutrophil, including chronic neutrophilic leukemia and congenital and autoimmune neutropenia.
Richard Godby, M.D.
Richard Godby, M.D., is a hematologist and assistant professor at Mayo Clinic in Rochester, Minnesota. He is board certified in internal medicine, hematology, medical oncology, and transfusion medicine and blood banking.
Dr. Godby’s clinical interests include classical hematology, immunohematology, immune thrombocytopenia, hemolytic anemias, transfusion medicine, iron disorders, complex diagnostics, and rare diseases. His academic interests include medical education for both providers and patients, public health literacy and shared decision making, healthcare delivery and experience, pragmatic clinical implementation initiatives, quality improvement, and systems-based hematology.
Dr. Godby enjoys working collaboratively in teams and is often joined by learners in both the inpatient and outpatient settings. He is involved in several professional societies and multidisciplinary research resulting in multiple manuscripts, book chapters, abstracts, and presentations.
Mustaqeem A. Siddiqui, M.D., M.B.A.
Dr. Mustaqeem A. Siddiqui, M.D., M.B.A., is an Assistant Professor of Medicine at the Mayo Clinic College of Medicine and Science, where he specializes in hematology and oncology. After earning his medical degree from Aga Khan University in 2002, he completed his internal medicine residency and a fellowship in hematology‑oncology, both at Mayo Clinic. He later pursued an M.B.A. at the University of Chicago Booth School of Business, reflecting his interest in the intersection of medicine and healthcare systems.
Dr. Siddiqui has authored more than 40 peer‑reviewed publications, including research on multiple myeloma, lymphoma, amyloidosis, and cost‑effectiveness in cancer care. He is an active investigator in CAR‑T cell therapies and serves as a principal investigator on clinical trials exploring innovative treatments for hematologic malignancies. His professional memberships include the American Society of Clinical Oncology and the American Society of Hematology.
Beyond his clinical and research work, Dr. Siddiqui is deeply interested in healthcare economics and entrepreneurship, striving to translate scientific advances into efficient, patient‑centered care models that improve access and outcomes for patients with complex hematologic diseases.
Meera Sridharan, M.D., Ph.D.
Dr. Meera Sridharan, M.D., Ph.D., is a hematologist and oncologist at Mayo Clinic in Rochester, Minnesota, serving as Assistant Professor of Medicine and Consultant in the Division of Hematology. She earned her dual M.D. and Ph.D. degrees from Saint Louis University, followed by residency training in Internal Medicine and fellowships in Hematology, Medical Oncology, and Special Coagulation at Mayo Clinic.
Board-certified in Internal Medicine, Hematology, and Medical Oncology, Dr. Sridharan also holds certification in Quality Improvement from the Mayo Clinic Quality Academy. Her clinical and research interests focus on thrombotic microangiopathies, complement-mediated disorders, coagulation factor deficiencies (both acquired and congenital), immune thrombocytopenia, and autoimmune hemolytic anemia. She has played a key role in developing treatment guidelines for thrombotic microangiopathies through her involvement with the CAP-TMA group.
Dr. Sridharan is an accomplished scholar with more than 40 peer-reviewed publications, book chapters, and scientific abstracts. In addition to her research, she is deeply committed to medical education and curriculum development, having received recognition for her excellence in clinical teaching, including as one of the highest-rated clinical educators within Mayo Clinic’s Internal Medicine Residency Program.
Rajiv K. K. Pruthi, M.B.B.S.
Mayo Clinic in Rochester, Minnesota. He holds board certifications in internal medicine, hematology, and medical oncology.
Dr. Pruthi earned his medical degree from Kasturba Medical College in India and subsequently pursued internal medicine and hematology/oncology training at Mayo Clinic. His career has been shaped by a deep interest in disorders of coagulation, bleeding, and thrombosis.
At Mayo Clinic, Dr. Pruthi serves as Director of the Hemophilia Treatment Center and Co‑Director of the Special Coagulation and Molecular Hematopathology laboratories. His research focuses on translational science—developing molecular and genetic diagnostic tools for coagulation disorders and improving patient care in bleeding and thrombotic diseases.
Beyond his clinical and research contributions, Dr. Pruthi is a dedicated educator and mentor. He has received several awards for teaching excellence and patient care, and has published widely in his field, reflecting his enduring commitment to advancing hematology through both discovery and compassionate patient-centered care.
Rachelle Rouse, APRN, CNP, AOCNP
Rachelle Rouse, is a nurse practitioner specializing in classical (non‑malignant) hematology at the Mayo Clinic in Rochester, Minnesota. After completing Mayo Clinic’s post‑graduate hematology APP (Advanced Practice Provider) fellowship, she assumed a role within the outpatient hematology team, where she works with patients dealing with complex blood disorders.
Ms. Rouse’s earlier training included oncology-focused studies at Yale School of Nursing, which laid a foundation for her interest in hematology and hematologic disease management. She is particularly drawn to the diagnostic challenges inherent in hematology and is passionate about supporting and expanding rigorous training for advanced practitioners in hematology and oncology.
In her clinical scholarship, she has co‑authored research on workforce issues in classical hematology and on trial eligibility criteria affecting minority participation in oncology studies. Her advice to emerging fellows underscores the importance of enjoying the learning journey, being patient with oneself, and leveraging Mayo Clinic’s supportive environment to grow in autonomy and expertise.
Stephan Thomé, MD
Dr. Thomé was born Frankfurt am Main, West Germany, and after Gymnasium (German high-school) enjoyed his first taste of biomedical science in a 3 month stint as research assistant at the cardiovascular pharmacology research lab under Professor Paul VanHoutte at Mayo Rochester. Immediately after he completed his required military service in the German airforce and went on to earn his medical degree (University of Ulm). Ulm is situated on the Danube river across from Neu-Ulm, Bavaria, and is home to the world’s tallest church spire atop the Ulmer cathedral. He started his residency in internal medicine in the department of Internal Medicine III (focus Hematology/Oncology) at Ulm University Hospital, followed by several rotations as Junior and Senior House Officer in the UK (Truro, Cornwall, Noble, Isle of Man, Oxford, Bath) followed by completing internal medicine residency PGY2-3 at Mayo Clinic Rochester, then fellowship in hematology-oncology at the Mayo Clinic in Rochester, Minnesota (on loan for his first year to Mayo Jacksonville as they started their H/O fellowship program). He was fortunate to spend part of his a research year under the mentoring and tutelage of Dr. Bill Nichols in coagulation. He practiced as a community hematologist in Omaha, Nebraska for a decade (with one year working for Marshfield clinic in Minocqua, WI) before rejoining the staff at Mayo Clinic in the Division of Community Oncology in 2012. Dr. Thomé currently is a member of Classical (Benign) Hematology in the Division of Hematology at Mayo Clinic Rochester. His clinical and research interests in classical hematology clude immune hematologic disorders (ITP, Factor inhibitors, AIHA), immunohematology, management of microangiopathies. He serves as Vice Chair on the Mayo Pharmaceutical Formulary Committee, and as member of MNCCTN (Trial Review Committee, local PI) after leading the successful establishment of regional QUOPI and ACS COC accreditations. He continues to enjoy helping patients stay healthy, working with his supportive colleagues, and having time with family and pastimes.
Alexandra Paula Wolanskyj-Spinner, MD, FACP
Dr. Wolanskyj-Spinner is a Professor of Medicine and Consultant in Hematology at Mayo Clinic in Rochester, Minnesota. She holds the Carla J. and Russell P. Paonessa Endowed Chair in Student Life and Wellness and serves as Medical Director of the Office of Wellness and Academic Support for the Mayo Clinic College of Medicine and Science across the Mayo Clinic enterprise.
Dr. Wolanskyj-Spinner’s research focuses on chronic myeloid neoplasms, thrombophilic disorders, and autoimmune cytopenias. She is also a leader in medical education with a focus on physician wellbeing, contributing scholarly work in resilience training, learner support, and the integration of humanities in medicine. She has authored over 80 peer-reviewed publications and led multiple educational innovations across the Mayo Clinic College of Medicine and Science.